Overfunding on SyndicateRoom, Fertility Focus Says Exit Could Deliver 10X Return to Investors, According to Company

The UK company Fertility Focus and its product Ovusense is said to deliver a 99% accuracy in predicting ovulation. The company states that 30% of women have ovulatary issues – most of which are difficult to discern. They also state that over 50% of women are… Read More
Read more in: Global, Offerings | Tagged fertility focus, goncalo de vasconcelos, medical, medtech, syndicateroom, uk